145 related articles for article (PubMed ID: 32564236)
1. Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.
Moug SJ; Barry SJE; Maguire S; Johns N; Dolan D; Steele RJC; Buchan C; Mackay G; Anderson AS; Mutrie N
Tech Coloproctol; 2020 Sep; 24(9):959-964. PubMed ID: 32564236
[TBL] [Abstract][Full Text] [Related]
2. Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from the REx trial.
Moug SJ; Mutrie N; Barry SJE; Mackay G; Steele RJC; Boachie C; Buchan C; Anderson AS
Colorectal Dis; 2019 May; 21(5):548-562. PubMed ID: 30657249
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery.
Horie K; Matsuda T; Yamashita K; Hasegawa H; Utsumi M; Urakawa N; Kanaji S; Oshikiri T; Kakeji Y
Eur J Surg Oncol; 2022 Apr; 48(4):850-856. PubMed ID: 34756762
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of prehabilitation in patients undergoing elective cardiac surgery.
Akowuah EF; Wagnild JM; Bardgett M; Prichard JG; Mathias A; Harrison SL; Ogundimu EO; Hancock HC; Maier RH;
Anaesthesia; 2023 Sep; 78(9):1120-1128. PubMed ID: 37402352
[TBL] [Abstract][Full Text] [Related]
5. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma.
Levolger S; van Vledder MG; Alberda WJ; Verhoef C; de Bruin RWF; IJzermans JNM; Burger JW
Clin Nutr; 2018 Oct; 37(5):1728-1735. PubMed ID: 28756039
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
[TBL] [Abstract][Full Text] [Related]
7. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
[TBL] [Abstract][Full Text] [Related]
8. Patient's Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer.
Berkel AEM; Klaase JM; de Graaff F; Brusse-Keizer MGJ; Bongers BC; van Meeteren NLU
Dig Surg; 2019; 36(5):376-383. PubMed ID: 29898443
[TBL] [Abstract][Full Text] [Related]
9. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
West MA; Loughney L; Lythgoe D; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Br J Anaesth; 2015 Feb; 114(2):244-51. PubMed ID: 25274049
[TBL] [Abstract][Full Text] [Related]
10. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial.
Allen SK; Brown V; White D; King D; Hunt J; Wainwright J; Emery A; Hodge E; Kehinde A; Prabhu P; Rockall TA; Preston SR; Sultan J
Ann Surg Oncol; 2022 Mar; 29(3):1839-1850. PubMed ID: 34725764
[TBL] [Abstract][Full Text] [Related]
12. Physical activity programmes for patients undergoing neo-adjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis.
Latrille M; Buchs NC; Ris F; Koessler T
Medicine (Baltimore); 2021 Dec; 100(51):e27754. PubMed ID: 34941028
[TBL] [Abstract][Full Text] [Related]
13. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial).
Loughney L; West MA; Moyses H; Bates A; Kemp GJ; Hawkins L; Varkonyi-Sepp J; Burke S; Barben CP; Calverley PM; Cox T; Palmer DH; Mythen MG; Grocott MPW; Jack S;
Perioper Med (Lond); 2021 Jun; 10(1):23. PubMed ID: 34154675
[TBL] [Abstract][Full Text] [Related]
14. Prehabilitation in Patients With Breast Cancer Receiving Neoadjuvant Therapy to Minimize Musculoskeletal Postoperative Complications and Enhance Recovery (PREOPtimize): A Protocol for a Randomized Controlled Trial.
Casanovas-Álvarez A; Sebio-Garcia R; Ciendones M; Cuartero J; Estanyol B; Padrós J; García-Valdecasas B; Barnadas A; Masia J
Phys Ther; 2023 Sep; 103(9):. PubMed ID: 37318267
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia in Patients With Rectal Adenocarcinoma: An Opportunity for Preoperative Rehabilitation.
Bliggenstorfer JT; Hashmi A; Bingmer K; Chang C; Liu JC; Ginesi M; Stein SL; Steinhagen E
Am Surg; 2023 Dec; 89(12):5631-5637. PubMed ID: 36896832
[TBL] [Abstract][Full Text] [Related]
16. S184: preoperative sarcopenia is associated with worse short-term outcomes following transanal total mesorectal excision (TaTME) for rectal cancer.
Springer JE; Beauharnais C; Chicarilli D; Coderre D; Crawford A; Baima JA; McIntosh LJ; Davids JS; Sturrock PR; Maykel JA; Alavi K
Surg Endosc; 2022 Jul; 36(7):5408-5415. PubMed ID: 34988741
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
Takeda Y; Akiyoshi T; Matsueda K; Fukuoka H; Ogura A; Miki H; Hiyoshi Y; Nagasaki T; Konishi T; Fujimoto Y; Fukunaga Y; Ueno M
PLoS One; 2018; 13(4):e0195406. PubMed ID: 29630652
[TBL] [Abstract][Full Text] [Related]
18. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
[TBL] [Abstract][Full Text] [Related]
19. The relationship between sarcopenia and survival at 1 year in patients having elective colorectal cancer surgery.
Dolan DR; Knight KA; Maguire S; Moug SJ
Tech Coloproctol; 2019 Sep; 23(9):877-885. PubMed ID: 31486988
[TBL] [Abstract][Full Text] [Related]
20. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
Park JW; Kang SB; Hao J; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim JS; Lee HS; Kim JH; Jeong SY; Oh JH
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):569-577. PubMed ID: 33894918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
